By Dr Chris Jolly

Preprints

Thoms JAI; Yan F; Hampton H; Davidson S; Joshi S; Saw J; Sarowar C; Lim XY; Nunez A; Kakadia P; Bhuyan GS; Zou X; Nguyen M; Ghodousi E; Koch F; Vafaee F; Pickford R; Raftery M; Hough S; Buckland G; Bailey M; Ghodke Y; Absar N; Vaughan L; Pasalic L; Fong C; Kenealy M; Hiwase D; Stoddart R; Mohammed S; Lee L; Passam F; Larsen S; Spring K; Skarratt K; Rebeiro P; Presgrave P; Stevenson W; Ling S; Tiley C; Fuller S; Roncolato F; Enjeti A; Hoenemann D; Lemech C; Jolly C; Bohlander S; Curtis D; Wong J; Unnikrishnan A; Hertzberg M; Olivier J; Polizzotto M; Pimanda J, 2024, Clinical Response to Azacitidine in Myelodysplastic Neoplasms is Associated with Distinct DNA Methylation Changes in Haematopoietic Stem and Progenitor cellsin vivo, http://dx.doi.org/10.1101/2024.07.19.24310679

Truong P; Shen S; Joshi S; Islam MI; Zhong L; Raftery M; Afrasiabi A; Alinejad-Rokny H; Nguyen M; Zou X; Bhuyan GS; Sarowar C; Ghodousi E; Stonehouse O; Mohamed S; Toscan C; Connerty P; Kakadia P; Bohlander S; Michie K; Larsson J; Lock R; Walkley C; Thoms J; Jolly C; Pimanda J, 2024, Genome-Wide CRISPR-Cas9 Screening Identifies a Synergy between Hypomethylating Agents and SUMOylation Blockade in MDS/AML, http://dx.doi.org/10.1101/2024.04.17.589858

Schnegg-Kaufmann A; Thoms J; Bhuyan GS; Hampton H; Vaughan L; Rutherford K; Kakadia P; Johansson E; Failes T; Arndt G; Koval J; Lindeman R; Warburton P; Rodriguez-Meira A; Mead A; Unnikrishnan A; Bohlander S; Papaemmanuil E; Faridani O; Jolly C; Zanini F; Pimanda J, 2022, Single cell genotyping of matched bone marrow and peripheral blood cells in treatment naive and AZA-treated MDS and CMML, http://dx.doi.org/10.1101/2022.01.20.476890

Michel AO; Donovan TA; Roediger B; Lee Q; Jolly C; Monette S, 2021, Chaphamaparvovirus Antigen and Nucleic Acids are not Detected in Kidney Tissues from Cats with Chronic Renal Disease or Immunosuppressive Diseases, http://dx.doi.org/10.1101/2021.03.30.437777

Back to profile page